Filling Equipment

Pharma Tech Readies Line for New Nasal Delivery Device

Custom filling, line automation, and humidity control are developed as OptiNose prepares for an NDA filing.
As an outsourcing partner with pharmaceutical companies, Pharm Tech Industries (PTI; www.pharma-tech.com) often develops complete solutions for customers in providing turnkey contract manufacturing and packaging services.
The Royston, GA–based CMO and packager draws on a staff of in-house engineers to accomplish a technology transfer and to meet custom requirements with first-of-kind solutions.
For the OptiNose Delivery System, PTI is developing a complex filling and packag
No votes yet

Groninger Provided Equipment to Two Facility of the Year Award Winners

Two pharmaceutical projects to be recognized in the "Facility of the Year" program at Interphex 2013 featured equipment from Groninger. Among the winners were F. Hoffmann La Roche Ltd. and Novartis Vaccines and Diagnostics, both of which utilized machinery from Groninger, the company reported in a press release.

Romaco To Unveil Two New High Speed Filling Models

Romaco, Karlsruhe/Germany, is extending its Macofar LF 200 product family with two more models for filling liquids into glass and plastic bottles at high speeds.

Vetter Launches New Syringe Filling Line

Vetter announced that its new award-winning filling line is fully validated and ready for cGMP filling, after successful media-fill completion. One customer project is underway, with more in the wings, the company said.

MWV Expands Pharmaceutical Manufacturing Centre of Excellence

MeadWestvaco Corporation has announced the expansion of its pharmaceutical manufacturing Centre of Excellence, based in Hemer, Germany.
The Centre is the core for MWV’s global pharmaceutical dispensing systems manufacturing network. The $7.5 million project includes expanding clean room molding and assembly capacity, and the introduction of a state-of-the-art logistics system to control the flow of finished goods and components.

Bosch Delivers Syringe-Filling Line to Drug Contractor in Italy

IBSA Farmaceutici Italia, a subsidiary of the Swiss Institute Biochimique S.A., aseptically fills and sterilizes syringes. At its site in Lodi, for instance, IBSA fills 16 million pre-filled syringes with sodium hyaluronate for intra-articular and intradermal use and 2.2 million syringes with solvents for freeze-dried powders. To meet increasing demand for prefilled syringes, IBSA added a new production building featuring Bosch Packaging Technology’s (www.boschpackaging.com) FXS nested syringe filling.

Romaco Exhibits Tube Filler For Pharma Packaging

Romaco is showcasing the Romaco Unipac U 2060 automatic tube filler at PackExpo, booth S-232. The filler has an enclosed design that meets ergonomic requirements. With a compact structure and a footprint of less than one and a half square metres, the unit is easy to access and extremely versatile.

Vetter Filling Line Lands European Honors

The company has received Most Improved Manufacturing Project or Process at the European Outsourcing Awards.

Vetter has been awarded first place for the category Most Improved Manufacturing Project or Process at this year’s European Outsourcing Awards. The application for the company’s new high-speed filling line for pre-sterilized syringes was the top choice among the jury of experts due to its intelligent concepts and systems. The award was given to the company at a gala dinner on October 10, during the CPHI Worldwide/iCSE show in Madrid.

No votes yet

Catalent Increases Sterile Fill-Finish Capacity

Catalent Pharma Solutions has completed construction of its newly-renovated 3300-sq-ft aseptic fill-finish manufacturing facility at Research Triangle Park, NC, where it offers comprehensive sterile product formulation and development.
The renovation provides a four-fold increase of the sterile fill-finish capacity at the site and adds new complementary technology to Catalent’s existing service offerings (see http://www.catalent.com/index.php/development, http://www.catalent.com/index.php/supply).
Your rating: None Average: 5 (1 vote)

Factoring Social Costs

In evaluating scenarios for its business after a 2007 management buyout, Pharmalucence managers considered the impact on employment.
“We were at the bottom of the recession where jobs were being lost; we didn’t want to be part of that,” President Glenn Alto said in a presentation “Making It Massachusetts” at Interphex.
Outsourcing pharmaceutical production—one of the options considered—would downsize the firm by more than 50 employees.
No votes yet
Syndicate content